Clifford A. Hudis MD
Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer CenterDr. Hudis is a medical oncologist with research interests in all areas of care related to breast cancer. His clinical practice is solely devoted to the treatment of patients with breast cancer, and his research is focused on prevention of the disease, prevention of occurrence after surgery, and treatment of recurrences.
Working with a broad team of experts at Memorial Sloan-Kettering Cancer Center (MSKCC) and throughout the world, he is involved in clinical and translational studies that aim to develop better hormone therapies, improved chemotherapy drugs, more effective and less toxic methods of drug delivery, and newer, highly specific agents. Dr. Hudis conducts this work at MKCC, through the Breast Cancer Disease Management Team and the Breast Cancer Medicine Service, and also through his role as the Breast Committee Co-chair of the Cancer and Leukemia Group B, a national clinical research group sponsored by the National Cancer Institute. In addition, he serves on the editorial boards of several leading cancer journals and in several capacities with the American Society of Clinical Oncology.
Positions:
Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center
Degree:
The Medical College of Pennsylvania, MD
Postgraduate Training:
Resident, Hospital of the Medical College of Pennsylvania
Resident, Philadelphia Veterans Administration Hospital
Fellow, Memorial Sloan-Kettering Cancer Center
Board Certifications:
Medical oncology
Clinical Interests:
Breast cancer
Recent Contributions to PracticeUpdate:
- Ask the Expert: What’s the Role for Post-Mastectomy Radiation and Chemotherapy in Node-Positive Breast Cancer?
- Ask the Expert: Applying BOLERO-2 to the “Hormone-Refractory” Patient
- Dr. Clifford Hudis: 2011 Top Stories in Breast Cancer—Chemoprevention, Novel Agents, Less Surgery
- New Drugs—What's Important?